For the Inventor, By the Inventor

Enter assignee name

Pluristem Ltd.

USPTO Granted Patents = 21

CIPO Patents = 3

EPO Patents = 25

Forward Citations = 218

Loading Chart...

Loading Chart...

30 inventors (with patents filed for the assignee):

Harel Kasuto (6 out of 6 patents)

Rachel Ofir (6 out of 6 patents)

Moran Meiron (6 out of 6 patents)

4. Eytan Abraham (6 out of 17 patents)

5. Zami Aberman (5 out of 6 patents)

6. Amir Toren (5 out of 5 patents)

7. Nirit Drori-Carmi (5 out of 5 patents)

8. Lior Raviv (3 out of 6 patents)

9. Nirit Drori-carmi (2 out of 2 patents)

10. Barak Zohar (2 out of 2 patents)

11. Ohad Karnieli (2 out of 2 patents)

12. Georg N Duda (1 out of 12 patents)

13. Avinoam Kadouri (1 out of 6 patents)

14. Raphael Gorodetsky (1 out of 14 patents)

15. Nadav Eshkol (1 out of 1 patent)

21 patents: Sort by Forward Citations

1. 10851347 - Altered adherent stromal cells and methods of producing and using same (2020-12-01),

2. 10851341 - Methods and systems for harvesting cells (2020-12-01),

3. 10722541 - Methods for treating radiation or chemical injury (2020-07-28),

4. 10610545 - Adherent cells from placenta and use of same in disease treatment (2020-04-07),

5. 10392593 - Systems and methods for growing and harvesting cells (2019-08-27),

6. 10351910 - Gene and protein expression properties of adherent stromal cells cultured in 3D (2019-07-16),

7. 10258652 - Methods and compositions for treating and preventing muscle wasting disorders (2019-04-16),

8. 10251389 - Method and device for thawing biological material (2019-04-09),

9. 9950014 - Methods for prevention and treatment of preeclampsia (2018-04-24),

10. D802157 - Carrier for cell culture (2017-11-07),

11. D800334 - Carrier for cell culture (2017-10-17),

12. 9758762 - Perfusion bioreactor for culturing CD200—placenta adherent cells (2017-09-12),

13. 9757419 - Skeletal muscle regeneration using mesenchymal system cells (2017-09-12),

14. 9657266 - Methods and systems for harvesting cells (2017-05-23),

15. 9517248 - Adherent cells from adipose or placenta tissues and use thereof in therapy (2016-12-13),

Pluristem Ltd. is a leading regenerative medicine company that develops and manufactures placenta-based cell therapy products. The company's cutting-edge technology harnesses the therapeutic potential of placental cells to develop innovative treatments for a wide range of diseases and medical conditions. Pluristem's products have shown promising results in clinical trials for conditions such as critical limb ischemia, muscle injury, and acute radiation syndrome.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

21 Patents

#12 in Haifa

#269 in Israel

#29,052 in the World

Pluristem Ltd.

Forward Citations = 218

30 inventors:

Harel Kasuto (6 out of 6 patents)

Rachel Ofir (6 out of 6 patents)

Moran Meiron (6 out of 6 patents)

4. Eytan Abraham (6 out of 17 patents)

5. Zami Aberman (5 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…